Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | GHSR | Q92847 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30490005 | 1.00 | OPRM1 (0.54) | OPRM1OPRD1GHSR | |
| SCHEMBL31171024 | 0.94 | OPRM1 (0.54) | OPRM1OPRD1GHSR | |
| SCHEMBL34464899 | 0.93 | OPRM1 (0.50) | OPRM1OPRD1GHSR | |
| SCHEMBL30490008 | 0.93 | TACR1 (0.51) | — | |
| SCHEMBL30506402 | 0.91 | LTA4H (0.58) | OPRM1OPRD1GHSR | |
| SCHEMBL30958546 | 0.91 | LTA4H (0.58) | OPRM1OPRD1GHSR | |
| SCHEMBL29564909 | 0.91 | OPRM1 (0.63) | OPRM1OPRD1GHSR | |
| SCHEMBL29577130 | 0.90 | LTA4H (0.57) | GHSR | |
| SCHEMBL30799784 | 0.90 | GHSR (0.57) | GHSR | |
| SCHEMBL29577979 | 0.90 | LTA4H (0.57) | GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116964071-B | Hexapeptide, composition and application thereof | 深圳市维琪科技股份有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240342071-A1 | HEXAPEPTIDE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | SHENZHEN WINKEY TECHNOLOGY CO., LTD (CN) | 2024-10-17 | — | — | US | claimed |
| EP-4442696-A1 | HEXAPEPTIDE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | Shenzhen Winkey Technology Co., Ltd (CN) | 2024-10-09 | — | — | EP | claimed |
| CN-116964071-A | Hexapeptide and cosmetic composition or medicinal composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| WO-2023123479-A1 | HEXAPEPTIDE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | 深圳市维琪科技股份有限公司 | 2023-07-06 | — | — | WO | claimed |
| CN-116964071-B | Hexapeptide, composition and application thereof | 深圳市维琪科技股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| US-20240342071-A1 | HEXAPEPTIDE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | SHENZHEN WINKEY TECHNOLOGY CO., LTD (CN) | 2024-10-17 | — | — | US | disclosed |
| EP-4442696-A1 | HEXAPEPTIDE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | Shenzhen Winkey Technology Co., Ltd (CN) | 2024-10-09 | — | — | EP | disclosed |
| CN-116964071-A | Hexapeptide and cosmetic composition or medicinal composition and application thereof | 深圳市维琪科技股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023123479-A1 | HEXAPEPTIDE, COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | 深圳市维琪科技股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240342071-A1 | HEXAPEPTIDE,COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE OF HEXAPEPTIDE | MC1R, PROKR1, MITF | OPRM1 2203/4885OPRD1 1913/4885GHSR 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.